SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-20-096782
Filing Date
2020-08-19
Accepted
2020-08-19 11:58:07
Documents
1
Group Members
DR. JAMES I. HEALYDR. MICHAEL F. POWELLSOFINNOVA MANAGEMENT IX, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2028968d1_sc13d.htm SC 13D 98125
  Complete submission text file 0001104659-20-096782.txt   99740
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners IX, L.P. (Filed by) CIK: 0001612133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Subject) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91617 | Film No.: 201115985
SIC: 2836 Biological Products, (No Diagnostic Substances)